Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
When redeeming rewards, several factors can influence your choices. Learn what to consider to ensure you get the best value for your points.
17,088 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
June's trading floor is flashing mixed signals: a SpaceX-inspired rally taps telecom names, but EchoStar pulls back o...
U.S. stocks and futures react to a fresh batch of analyst calls on Dynatrace, Emerson Electric, Exxon Mobil and more....
Compass is broadening its northern Arizona footprint with a new leadership lineup in Flagstaff, aiming to capture lux...
Franklin Templeton filed for two DRIP-focused ETFs that would redirect dividend payouts from U.S. stocks into Bitcoin...
Netflix trades below $78 as investors weigh ad-supported growth and margin targets. Analysts dispute whether the stoc...
As Costco shares hover near $970, analysts outline a constructive path to $1,000 and beyond, driven by membership mom...
U.S. corporations are accelerating stock repurchases, widening participation beyond mega-cap tech and triggering a br...
Investors face a choice between a pharmaceutical powerhouse with proven earnings and a high-growth space company unde...
Meta Platforms is weighing a bold move into prediction markets, boosting investor interest and triggering a rally. An...
FEPI’s high yield relies on aggressive call-writing against a tech-heavy basket. While payouts appear robust, scrutin...
U.S. grid operators and policymakers set a 2027 deadline for bitcoin miners to demonstrate they help, not hurt, relia...